Markets:

Overview

News

Currencies

International

Treasuries

Aquestive Therapeutics, Inc. - Common Stock (NQ:AQST)

4.665 -0.005 (-0.11%)

Streaming Delayed Price Updated: 3:25 PM EDT, Sep 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aquestive Therapeutics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Earnings Outlook For Aquestive Therapeutics ↗

March 06, 2023

Via Benzinga

Aquestive Therapeutics to Participate in Oppenheimer 33rd Annual Healthcare Conference

March 01, 2023

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics to Report Fourth Quarter 2022 Financial Results and Recent Business Highlights on March 7 and Host Conference Call on March 8 at 8:00 a.m. ET

February 22, 2023

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for AQST-109 Epinephrine Sublingual Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

February 21, 2023

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Inks Supply Pact For Its Seizure Treatment Covering European, Middle East Countries ↗

September 28, 2022

Via Benzinga

Aquestive's AQST-109 Compares Favorably To Widely Used EpiPen For Severe Allergic Reaction ↗

September 27, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 15, 2023

Via Benzinga

Aquestive Therapeutics Provides Business Update and Outlines Key 2023 Objectives

January 06, 2023

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics Announces Completion of FDA End-of-Phase 2 Meeting For AQST-109 (epinephrine sublingual film)

December 22, 2022

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics Announces Publication of Crossover Food Effect Study of Diazepam Nasal Spray in Epilepsia

November 29, 2022

Peer-reviewed data indicates that food significantly decreases and delays the absorption of diazepam dosed via nasal spray

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences

November 15, 2022

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic Studies for AQST-109 (epinephrine sublingual film) at American Academy of Allergy, Asthma, and Immunology (ACAAI) Annual Scientific Meeting

November 09, 2022

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Looking Into Aquestive Therapeutics's Return On Capital Employed ↗

November 09, 2022

According to data from Benzinga Pro, during Q3, Aquestive Therapeutics's (NASDAQ:AQST) reported sales totaled $11.46 million. Despite a 23.1% increase in earnings, the company posted a loss of $12.54...

Via Benzinga

Aquestive Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

November 01, 2022

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics Earnings Preview ↗

October 31, 2022

Aquestive Therapeutics (NASDAQ:AQST) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Aquestive Therapeutics Licenses Sympazan® (clobazam) Oral Film to Assertio Holdings, Inc.

October 27, 2022

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics Announces Positive Decision in States’ Suboxone Antitrust Lawsuit on All Claims

October 24, 2022

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics to Report Third Quarter 2022 Financial Results and Recent Business Highlights on November 1 and Host Conference Call on November 2 at 8:00 a.m. ET

October 19, 2022

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Aquestive Therapeutics Receives Positive FDA Written Response for AQST-109 Epinephrine Sublingual Film

October 11, 2022

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

NASDAQ:AQST Investor Notice: Investigation over Potential Wrongdoing at Aquestive Therapeutics, Inc. ↗

September 29, 2022

San Diego, CA -- (SBWIRE) -- 09/29/2022 -- Certain directors of Aquestive Therapeutics, Inc. are under investigation on over potential breaches of fiduciary duties.

Via SBWire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 28, 2022

Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million.

Via Benzinga

Aquestive Therapeutics Enters License and Supply Agreement with Pharmanovia for Libervant™ (diazepam) Buccal Film for European and MENA Markets

September 28, 2022

From Aquestive Therapeutics, Inc.

Via GlobeNewswire

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗

September 28, 2022

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 27, 2022

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.

Via Benzinga

Aquestive Therapeutics (AQST) Stock Gains on Positive Data for EpiPen Rival ↗

September 27, 2022

Aquestive Therapeutics (AQST) stock is taking off Tuesday as investors react to positive clinical trial data from the pharmaceutical company.

Via InvestorPlace

Why Is Aquestive Therapeutics Stock Up Today? ↗

September 27, 2022

Aquestive Therapeutics Inc (NASDAQ: AQST) shares are trading higher Tuesday after the company announced results from the EPIPHAST II trial for its AQST-109 epinephrine sublingual film.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 27, 2022

Gainers 9 Meters Biopharma (NASDAQ:NMTR) stock moved upwards by 22.8% to $0.25 during Tuesday's pre-market session. The company's market cap stands at $65.8 million.

Via Benzinga

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗

September 07, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.

Via Benzinga

Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday ↗

September 08, 2022

Gainers

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗

September 07, 2022

Upgrades

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.